Sven Dethlefs, EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 154,842 shares at $9.93 ($1.5M) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Seasonal sale ($1.5M) by EVP, North America Commercial — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.93 | 19,355 | $192K | 13.0% |
| 2 | $9.93 | 19,355 | $192K | 13.0% |
| 3 | $9.43 | 58,066 | $548K | 37.0% |
| 4 | $9.43 | 58,066 | $548K | 37.0% |
| Total | $9.55 avg | 154,842 | $1.5M | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $40K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $37K | — | Filing → |
| TEVA | SELL | 2021-03-08 | $127K | — | Filing → |